NO20012443L - Benzoksazolderivater og legemidler inneholdende disse som aktiv bestanddel - Google Patents

Benzoksazolderivater og legemidler inneholdende disse som aktiv bestanddel

Info

Publication number
NO20012443L
NO20012443L NO20012443A NO20012443A NO20012443L NO 20012443 L NO20012443 L NO 20012443L NO 20012443 A NO20012443 A NO 20012443A NO 20012443 A NO20012443 A NO 20012443A NO 20012443 L NO20012443 L NO 20012443L
Authority
NO
Norway
Prior art keywords
group
lower alkyl
alkyl group
active ingredient
salt
Prior art date
Application number
NO20012443A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012443D0 (no
Inventor
Sojiro Shiokawa
Yasuo Sato
Masaaki Izumi
Satoshi Yoshida
Hiroshi Murakami
Tomoko Ito
Tetsutaro Niisato
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of NO20012443D0 publication Critical patent/NO20012443D0/no
Publication of NO20012443L publication Critical patent/NO20012443L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20012443A 1998-11-20 2001-05-18 Benzoksazolderivater og legemidler inneholdende disse som aktiv bestanddel NO20012443L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33127498 1998-11-20
PCT/JP1999/006491 WO2000031073A1 (fr) 1998-11-20 1999-11-19 Derives de benzoxazole et produits a base de ces derniers utilises comme ingredient actif

Publications (2)

Publication Number Publication Date
NO20012443D0 NO20012443D0 (no) 2001-05-18
NO20012443L true NO20012443L (no) 2001-07-12

Family

ID=18241866

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012443A NO20012443L (no) 1998-11-20 2001-05-18 Benzoksazolderivater og legemidler inneholdende disse som aktiv bestanddel

Country Status (23)

Country Link
US (1) US7045516B1 (es)
EP (1) EP1134220B1 (es)
JP (1) JP4557112B2 (es)
KR (1) KR100675033B1 (es)
CN (1) CN1333771A (es)
AT (1) ATE273974T1 (es)
AU (1) AU753797B2 (es)
BR (1) BR9916793A (es)
CA (1) CA2351446A1 (es)
CZ (1) CZ20011700A3 (es)
DE (1) DE69919575T2 (es)
ES (1) ES2222763T3 (es)
HU (1) HUP0104238A3 (es)
ID (1) ID30143A (es)
IL (1) IL143178A0 (es)
NO (1) NO20012443L (es)
PL (1) PL348426A1 (es)
RU (1) RU2204558C2 (es)
SK (1) SK6772001A3 (es)
TR (1) TR200101945T2 (es)
TW (1) TW520370B (es)
WO (1) WO2000031073A1 (es)
ZA (1) ZA200104620B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660858B2 (en) * 2001-03-28 2003-12-09 Lion Bioscience Ag 2-aminobenzoxazole derivatives and combinatorial libraries thereof
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
AU2003252738A1 (en) * 2002-08-09 2004-02-25 Ajinomoto Co., Inc. Remedy for intestinal diseases and visceral pain
WO2007005780A2 (en) * 2005-07-01 2007-01-11 Dynogen Pharmaceuticals, Inc. Compositions and methods for treating gastrointestinal hypomotility and associated disorders
CN101410385B (zh) 2006-03-28 2011-08-24 高点制药有限责任公司 具有组胺h3受体活性的苯并噻唑类
WO2010048514A1 (en) * 2008-10-23 2010-04-29 Albany Molecular Research, Inc. Synthesis of 2-aminobenzoxazole compounds
KR101579688B1 (ko) 2014-07-08 2015-12-24 재단법인 전남생물산업진흥원 좁쌀풀 추출물을 유효성분으로 함유하는 과민성 대장증후군에 의한 내장 통증 억제예방 또는 치료용 약학 조성물
GEP20247674B (en) * 2020-06-12 2024-09-25 Hk Inno N Corp Pharmaceutical composition comprising benzimidazole derivative compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3193560B2 (ja) * 1993-04-16 2001-07-30 明治製菓株式会社 新規ベンゾオキサゾール誘導体
JP3520177B2 (ja) * 1996-05-09 2004-04-19 明治製菓株式会社 セロトニン５−ｈｔ３受容体部分活性薬

Also Published As

Publication number Publication date
RU2204558C2 (ru) 2003-05-20
CA2351446A1 (en) 2000-06-02
HUP0104238A2 (en) 2002-08-28
ZA200104620B (en) 2002-02-04
CN1333771A (zh) 2002-01-30
US7045516B1 (en) 2006-05-16
BR9916793A (pt) 2001-11-13
ATE273974T1 (de) 2004-09-15
WO2000031073A1 (fr) 2000-06-02
SK6772001A3 (en) 2001-12-03
AU1185000A (en) 2000-06-13
DE69919575T2 (de) 2005-09-29
HUP0104238A3 (en) 2003-05-28
JP4557112B2 (ja) 2010-10-06
ID30143A (id) 2001-11-08
NO20012443D0 (no) 2001-05-18
ES2222763T3 (es) 2005-02-01
DE69919575D1 (de) 2004-09-23
TW520370B (en) 2003-02-11
EP1134220A4 (en) 2001-12-19
IL143178A0 (en) 2002-04-21
KR100675033B1 (ko) 2007-01-29
KR20010086448A (ko) 2001-09-12
CZ20011700A3 (cs) 2001-10-17
AU753797B2 (en) 2002-10-31
PL348426A1 (en) 2002-05-20
EP1134220A1 (en) 2001-09-19
TR200101945T2 (tr) 2001-11-21
EP1134220B1 (en) 2004-08-18

Similar Documents

Publication Publication Date Title
DK1213296T3 (da) Glucopyranosyloxpyrazolderivater, lægemidler indeholdende samme samt mellemprodukter til fremstilling heraf
NO970892L (no) Isoksazolderivater
ATE358484T1 (de) Antidiabetische medikamente
MX9701685A (es) Nuevos derivados de bencimidazol que tienen la actividad de inhibicion de la fosfodiestearasa cgmp.
EP0903347A4 (es)
EP0779074A4 (en) PROTECTIVE AGENT FOR ORGAN OR FABRIC
NO20012443D0 (no) Benzoksazolderivater og legemidler inneholdende disse som aktiv bestanddel
EP0808839A4 (en) EPOXYSUCCINAMIDE DERIVATIVES OR THEIR SALTS AND MEDICATIONS CONTAINING THEM
ATE223411T1 (de) 1-methylcarbapenem-derivate
EP1152004A4 (en) PHOSPHONIC ACID DERIVATIVES HAVING CARBOXYPEPTIDASE B INHIBITOR ACTIVITY
DE69812028D1 (de) Creatine Derivate für Asthma
HK1003890A1 (en) Optically active thiazolidinone derivatives
DE3889993D1 (de) 2'-Deoxy-5-fluorouridin-Derivate.
EP1201664A4 (en) BEMZIMIDAZOLE COMPOUNDS AND DRUGS CONTAINING THEM
DK0613897T3 (da) Piperidinderivater med anti-histamin-og anti-leukotrienaktivitet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application